JINS HOLDINGS Inc. (TYO:3046)
Japan
· Delayed Price · Currency is JPY 6,710.00
+10.00 (0.15%)
Apr 2, 2025, 3:30 PM JST
JINS HOLDINGS Revenue
JINS HOLDINGS had revenue of 21.06B JPY in the quarter ending November 30, 2024, with 15.91% growth. This brings the company's revenue in the last twelve months to 85.89B, up 15.47% year-over-year. In the fiscal year ending August 31, 2024, JINS HOLDINGS had annual revenue of 83.00B with 13.29% growth.
Revenue (ttm)
85.89B
Revenue Growth
+15.47%
P/S Ratio
1.82
Revenue / Employee
24.65M
Employees
3,485
Market Cap
156.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 83.00B | 9.74B | 13.29% |
| Aug 31, 2023 | 73.26B | 6.36B | 9.51% |
| Aug 31, 2022 | 66.90B | 3.00B | 4.70% |
| Aug 31, 2021 | 63.90B | 3.64B | 6.04% |
| Aug 31, 2020 | 60.26B | -1.64B | -2.64% |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Daiichi Sankyo Company | 1,795.99B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 837.44B |
| Otsuka Holdings | 2,329.86B |
| Terumo | 1,011.15B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |